🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Renaissance Technologies (RenTech)’s MMSI Holdings & Trades

First Buy
Q2 2013
Duration Held
41 Quarters
Largest Add
Q1 2015
+190,714 Shares
Current Position
314,212 Shares
$21.66 M Value

Renaissance Technologies (RenTech)'s MMSI Position Overview

Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 314,212 shares of Merit Medical Systems, Inc. (MMSI) worth $21.66 M, representing 0.03% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 41 quarters.

Based on 13F filings since 2013, Renaissance Technologies (RenTech) has maintained a long-term strategic position in MMSI, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2015, adding 190,714 shares. Largest reduction occurred in Q3 2017, reducing 296,800 shares.

Analysis based on 13F filings available since 2013 Q2

Renaissance Technologies (RenTech)'s Merit Medical Systems (MMSI) Holding Value Over Time

Track share changes against reported price movement

Quarterly Merit Medical Systems (MMSI) Trades by Renaissance Technologies (RenTech)

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q1 2026 +188,000 Add 148.96% 314,212 $68.93
Q4 2025 +51,300 Add 68.48% 126,212 $88.14
Q3 2025 -96,000 Reduce 56.17% 74,912 $83.23
Q2 2025 +4,300 Add 2.58% 170,912 $93.48
Q1 2025 +57,900 Add 53.26% 166,612 $105.71
Q4 2024 +15,400 Add 16.50% 108,712 $96.72
Q3 2024 -2,100 Reduce 2.20% 93,312 $98.83
Q2 2024 -18,200 Reduce 16.02% 95,412 $85.95
Q1 2024 +113,612 New Buy 113,612 $75.75
Q4 2023 -30,912 Sold Out 0 $0.00
Q3 2023 -24,800 Reduce 44.51% 30,912 $69.03
Q2 2023 -7,800 Reduce 12.28% 55,712 $0.08
Q1 2023 +63,512 New Buy 63,512 $0.07
Q3 2022 -25,409 Sold Out 0 $0.00
Q2 2022 +25,409 New Buy 25,409 $54.27
Q4 2021 -49,012 Sold Out 0 $0.00
Q3 2021 +26,200 Add 114.85% 49,012 $71.80
Q2 2021 +22,812 New Buy 22,812 $64.66
Q2 2019 -9,212 Sold Out 0 $0.00
Q1 2019 +9,212 New Buy 9,212 $61.88
Q2 2018 -30,012 Sold Out 0 $0.00
Q1 2018 +30,012 New Buy 30,012 $45.35
Q4 2017 -137,612 Sold Out 0 $0.00
Q3 2017 -296,800 Reduce 68.32% 137,612 $42.35
Q2 2017 +4,060 Add 0.94% 434,412 $38.15
Q1 2017 +128,952 Add 42.78% 430,352 $28.90
Q4 2016 +24,500 Add 8.85% 301,400 $26.50
Q3 2016 -85,300 Reduce 23.55% 276,900 $24.29
Q2 2016 -124,700 Reduce 25.61% 362,200 $19.83
Q1 2016 -41,000 Reduce 7.77% 486,900 $18.49
Q4 2015 -28,212 Reduce 5.07% 527,900 $18.59
Q3 2015 +129,373 Add 30.32% 556,112 $23.91
Q2 2015 +158,214 Add 58.92% 426,739 $21.54
Q1 2015 +190,714 Add 245.10% 268,525 $19.25
Q4 2014 +77,811 New Buy 77,811 $17.32
Q3 2014 -179,944 Sold Out 0 $0.00
Q2 2014 -57,003 Reduce 24.06% 179,944 $15.10
Q1 2014 +52,835 Add 28.70% 236,947 $14.30
Q4 2013 +66,100 Add 56.01% 184,112 $15.74
Q3 2013 +42,300 Add 55.87% 118,012 $12.13
Q2 2013 +75,712 Add 0.00% 75,712 $11.15

Renaissance Technologies (RenTech)'s Merit Medical Systems Investment FAQs

Renaissance Technologies (RenTech) first purchased Merit Medical Systems, Inc. (MMSI) in Q2 2013, acquiring 75,712 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Renaissance Technologies (RenTech) has held Merit Medical Systems, Inc. (MMSI) for 41 quarters since Q2 2013.

Renaissance Technologies (RenTech)'s largest addition to Merit Medical Systems, Inc. (MMSI) was in Q1 2015, adding 268,525 shares worth $5.17 M.

According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 314,212 shares of Merit Medical Systems, Inc. (MMSI), valued at approximately $21.66 M.

As of the Q1 2026 filing, Merit Medical Systems, Inc. (MMSI) represents approximately 0.03% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.

Renaissance Technologies (RenTech)'s peak holding in Merit Medical Systems, Inc. (MMSI) was 556,112 shares, as reported at the end of Q3 2015.